These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29671224)

  • 1. Effectiveness Evaluation of Additional Risk Minimization Measures for Adolescent Use of Aripiprazole in the European Union: Results from a Post-Authorization Safety Study.
    Landsberg W; Al-Dakkak I; Coppin-Renz A; Geis U; Peters-Strickland T; van Heumen E; Rahman M
    Drug Saf; 2018 Aug; 41(8):797-806. PubMed ID: 29671224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey.
    Lem J; Younus M; Aram JA; Moosavi S; Freivogel K; Lewis A; Sobel RE
    Pharmaceut Med; 2019 Apr; 33(2):121-133. PubMed ID: 31933256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effectiveness of an Educational Brochure as a Risk Minimization Activity to Communicate Important Rare Adverse Events to Health-Care Professionals.
    Bester N; Di Vito-Smith M; McGarry T; Riffkin M; Kaehler S; Pilot R; Bwire R
    Adv Ther; 2016 Feb; 33(2):167-77. PubMed ID: 26801772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Effectiveness of Apixaban Additional Risk Minimisation Measures Using Surveys in Europe.
    Mayall S; Kahlon R; Al-Dakkak I; Shen SW
    Pharmaceut Med; 2021 Mar; 35(2):123-135. PubMed ID: 33660230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
    Tramontina S; Zeni CP; Ketzer CR; Pheula GF; Narvaez J; Rohde LA
    J Clin Psychiatry; 2009 Apr; 70(5):756-64. PubMed ID: 19389329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Risk Minimization Measures to Prevent Pregnancy Exposure to Mycophenolate-Containing Medicines in Europe.
    Madison T; Donner B; Mutter R; Mingrino R; Alvaro G
    Pharmaceut Med; 2019 Oct; 33(5):395-406. PubMed ID: 31933233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports.
    LoCasale RJ; Datto C; Wilson H; Yeomans K; Coyne KS
    J Manag Care Spec Pharm; 2016 Mar; 22(3):236-45. PubMed ID: 27003553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Effectiveness of the Risk Minimization Measures of Sodium Oxybate in the European Union.
    Iranzo A; Serralheiro P; Schuller JC; Schlit AF; Bentz JWG
    Drugs Real World Outcomes; 2020 Dec; 7(4):307-315. PubMed ID: 32989679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of colistimethate sodium (COLOBREATHE) risk minimization measures implemented in the European Union: A cross-sectional study.
    Kaplan S; Patino O; Rainville C; Madison T
    Pharmacoepidemiol Drug Saf; 2020 Feb; 29(2):219-223. PubMed ID: 32914920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hiccups Associated with Aripiprazole in an Adolescent with Bipolar Disorder.
    Bilgiç A; Yılmaz S; Yılmaz E
    J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):656-7. PubMed ID: 26107167
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of switching to aripiprazole from current atypical antipsychotics on subsyndromal symptoms and tolerability in patients with bipolar disorder.
    Woo YS; Bahk WM; Park YM; Chung S; Yoon BH; Won S; Lee JG; Lee HB; Kim W; Jeong JH; Lee K; Kim MD
    Int Clin Psychopharmacol; 2016 Sep; 31(5):275-86. PubMed ID: 27487259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole Long-Acting Injectable for Maintenance Treatment of Bipolar I Disorder in Adults.
    Aggarwal A; Schrimpf L; Lauriello J
    Clin Schizophr Relat Psychoses; 2018 Jan; 11(4):221-223. PubMed ID: 29341822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.
    Keck PE; Marcus R; Tourkodimitris S; Ali M; Liebeskind A; Saha A; Ingenito G;
    Am J Psychiatry; 2003 Sep; 160(9):1651-8. PubMed ID: 12944341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obsessive-Compulsive Symptoms Associated With Aripiprazole Treatment in Bipolar Disorder: A Case Report.
    Gupta P; Gupta R; Balhara YP
    J Clin Psychopharmacol; 2017 Feb; 37(1):108-109. PubMed ID: 27930496
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial.
    Vieta E; Bourin M; Sanchez R; Marcus R; Stock E; McQuade R; Carson W; Abou-Gharbia N; Swanink R; Iwamoto T;
    Br J Psychiatry; 2005 Sep; 187():235-42. PubMed ID: 16135860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.
    Findling RL; Nyilas M; Forbes RA; McQuade RD; Jin N; Iwamoto T; Ivanova S; Carson WH; Chang K
    J Clin Psychiatry; 2009 Oct; 70(10):1441-51. PubMed ID: 19906348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic evaluation of the aripiprazole (once-monthly) injection for the treatment of bipolar disorder.
    Hebbrecht K; Morrens M; Neels H; Roosens L; Sabbe BGC
    Expert Opin Drug Metab Toxicol; 2018 Oct; 14(10):999-1005. PubMed ID: 30141352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
    Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH;
    J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aripiprazole, gambling disorder and compulsive sexuality].
    Mété D; Dafreville C; Paitel V; Wind P
    Encephale; 2016 Jun; 42(3):281-3. PubMed ID: 26923999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.